GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.

Cambridge, USA-based Vesalius Therapeutics has entered into a multi-target strategic alliance with the UK’s GSK to discover ...

GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

Here are today's five things you need to know, including a Ground Round comeback, employer confidence and JFK auction items you can own.

Thanks to Joseph Goebbels, the film director Georg Wilhelm Pabst luxuriated in a massive budget for the dramatised documentary he shot in occupied Prague during the autumn of 1942. Commissioned to ...

Inflammatix, a pioneering molecular diagnostics company, today announced initiation of the TriVerity™ for Improved Management of ...

Prior to its publication, the work of a Greek physician named Galen was the best, and only, guide on human anatomy. Vesalius's work was a significant step up, and this copy sold in 1998 is the only ...

GSK has licensed a small molecule for Parkinson's and is teaming up on additional targets for the disease and another ...